Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceutica...

FDA Drug Recall #D-0326-2021 — Class I — March 17, 2021

Recall Summary

Recall Number D-0326-2021
Classification Class I — Serious risk
Date Initiated March 17, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Alembic Pharmaceuticals Limited
Location Tajpura, N/A
Product Type Drugs
Quantity 12288 bottles

Product Description

Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30

Reason for Recall

Labeling: Label-mixup

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: 1905005661, Exp March 2022

Other Recalls from Alembic Pharmaceuticals Limited

Recall # Classification Product Date
D-0248-2026 Class III Fesoterodine Fumarate, Extended-release Tablets... Dec 16, 2025
D-0156-2026 Class III Fesoterodine Fumarate, Extended-release Tablets... Oct 10, 2025
D-0566-2025 Class II Doxepin Hydrochloride Capsules, USP, 10 mg, 100... Jul 25, 2025
D-0459-2025 Class II Celecoxib Capsules, 200 mg, 500-count bottle, R... May 9, 2025
D-0447-2025 Class II Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bot... May 7, 2025

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.